Close

Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c

August 1, 2014 6:34 AM EDT

Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.83), $0.51 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $5.74 million versus the consensus estimate of $9.72 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings